Mascoma Wealth Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Sell
3,800
-109
-3% -$33.1K 0.31% 33
2026
Q1
$835K Sell
3,909
-295
-7% -$66K 0.17% 46
2025
Q4
$720K Buy
4,204
+14
+0.3% +$2.18K 0.15% 46
2025
Q3
$561K Hold
4,190
0.12% 53
2025
Q2
$408K Hold
4,190
0.09% 60
2025
Q1
$305K Hold
4,190
0.08% 74
2024
Q4
$303K Hold
4,190
0.08% 77
2024
Q3
$342K Hold
4,190
0.09% 72
2024
Q2
$446K Hold
4,190
0.12% 60
2024
Q1
$407K Hold
4,190
0.12% 64
2023
Q4
$328K Hold
4,190
0.1% 73
2023
Q3
$263K Buy
4,190
+870
+26% +$57.2K 0.08% 85
2023
Q2
$231K Hold
3,320
0.07% 94
2023
Q1
$174K Sell
3,320
-60
-2% -$2.94K 0.05% 129
2022
Q4
$142K Sell
3,380
-70
-2% -$2.93K 0.05% 135
2022
Q3
$126K Sell
3,450
-100
-3% -$4.45K 0.04% 145
2022
Q2
$151K Sell
3,550
-150
-4% -$7.14K 0.05% 131
2022
Q1
$199K Buy
3,700
+3,040
+461% +$177K 0.06% 124
2021
Q4
$47K Buy
660
+250
+61% +$15.7K 0.02% 227
2021
Q3
$23K Buy
+410
New +$24.9K 0.01% 279
2021
Q2
Sell
-280
Closed -$17K 309
2021
Q1
$17K Buy
+280
New +$15.3K 0.01% 310

Other funds holding LRCX

Mascoma Wealth Management's LRCX Position: Q2 2026 in Review

Mascoma Wealth Management reduced its Lam Research (LRCX) stake by 2.8% in Q2 2026, selling an estimated $33.1K and leaving 3,800 shares worth $1.65M. The position accounts for 0.31% of the portfolio, ranked #33.

Mascoma Wealth Management first reported a position in LRCX in Q1 2021 and has held it in 21 quarters since. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Mascoma Wealth Management held 3,800 shares of Lam Research worth $1.65M as of Q2 2026.
  • Mascoma Wealth Management sold 109 Lam Research shares in Q2 2026, an estimated $33.1K.
  • Lam Research made up 0.31% of Mascoma Wealth Management's portfolio in Q2 2026, its #33 holding.
  • Mascoma Wealth Management first reported a position in Lam Research in Q1 2021 and has held it in 21 quarters since.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.